Imagen de Portada

Hidradenitis Suppurativa and Post‐Arthroplasty Wound Complications

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Dominique Digiacomo, Sahil Kapur, Bryce DeLong, Kermanjot S. Sidhu, Craig G. Burkhart
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	International Journal of Dermatology
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The Bidirectional Link Between Hidradenitis Suppurativa and Obstructive Sleep Apnea
por: Sahil Kapur, et al.
Publicado: (2025)

Joint Consequences of Chronic Inflammation: Exploring the Unexpected Association Between Hidradenitis Suppurativa and Adhesive Capsulitis
por: Kritin K. Verma, et al.
Publicado: (2025)

Haptoglobin Genotypes in Hidradenitis Suppurativa: Haptoglobin 2–2 Genotype Is Associated With Familial Hidradenitis Suppurativa and More Flares
por: Nessr Abu Rached, et al.
Publicado: (2025)

Association Between Hurley Stage and Comorbidities in Hidradenitis Suppurativa
por: Jack Fite, et al.
Publicado: (2025)

The Microbiome in Hidradenitis Suppurativa Tunnels: A Systematic Review
por: Alberto Soto‐Moreno, et al.
Publicado: (2025)

Smoking Tobacco Is Associated With Specific Phenotypes of Hidradenitis Suppurativa
por: Teja Mallela, et al.
Publicado: (2025)

Culture‐Confirmed Multifocal Scrofuloderma Mimicking Hidradenitis Suppurativa in an Adolescent
por: Deepak Juyal, et al.
Publicado: (2026)

Correction to “The Microbiome in Hidradenitis Suppurativa Tunnels: A Systematic Review”
Publicado: (2026)

Association of Treatment Burden With Quality of Life and Distress in Hidradenitis Suppurativa
por: Defne Özkoca, et al.
Publicado: (2026)

Use of PPE gowns to avoid scabies infestation and a 3‐day ivermectin therapy to reduce risk of spread of contagion
por: Craig G. Burkhart
Publicado: (2024)

From Inflammation to Circulation: Biologics Reduce Clot Risk in Hidradenitis Suppurativa
por: Zaryab Alam, et al.
Publicado: (2025)

Incidence of Anemia Subtypes in Hidradenitis Suppurativa: A Retrospective Cohort Study
por: Nuran C. Golbasi, et al.
Publicado: (2026)

Time to Reclassify Autoinflammatory Syndromes Linked to Acne, Hidradenitis Suppurativa, and Arthritis?
por: Patricia Garbayo‐Salmons, et al.
Publicado: (2026)

Association of Vitiligo With Metabolic and Cardiovascular Comorbidities: A Multicenter Propensity‐Matched Cohort Analysis
por: Kritin K. Verma, et al.
Publicado: (2026)

Seeking Role Models for Hidradenitis Suppurativa: From Historical Figures to Modern Advocates
por: Patricia Garbayo‐Salmons, et al.
Publicado: (2025)

Isolated Cutaneous Crohn's Disease of the Vulva and Gluteal Region With Coexisting Hidradenitis Suppurativa
por: Madhav Agrawal, et al.
Publicado: (2025)

Hidradenitis Suppurativa With Concomitant Arthritis: A Call for Disease Interception and Combination Therapy?
por: Simone Garcovich, et al.
Publicado: (2026)

Association Between Tobacco and Cannabis Use and Hidradenitis Suppurativa: A Retrospective Cohort Study
por: Naeha Pathak, et al.
Publicado: (2025)

Association Between Familial Inflammatory Diseases and Hidradenitis Suppurativa Severity: A Single‐Center Study
por: Defne Özkoca, et al.
Publicado: (2025)

Global Patterns of Comorbidities Among Patients With Hidradenitis Suppurativa: A Systematic Review and Meta‐Analysis
por: Aditya K. Gupta, et al.
Publicado: (2025)

Hidradenitis Suppurativa
Publicado: (2025)

Secondary Amyloidosis in Hidradenitis Suppurativa: A Case Series and a Proposal for Practical Screening Recommendations
por: Aida Lara‐Moya, et al.
Publicado: (2026)

Hidradenitis Suppurativa
Publicado: (2026)

Sweet Syndrome in Patients With Hidradenitis Suppurativa: A Population Study in the TriNetX Research Database
por: Racha Cherradi, et al.
Publicado: (2025)

Enhancing Healing in Hidradenitis Suppurativa With Tobacco Pouch Suture After CO2 Laser Excision Treatment
por: Martina Mussi, et al.
Publicado: (2025)

Position Statement of the EADV Task Forces With External Experts on Quality of Life Measurement in Hidradenitis Suppurativa: An Update
por: Pavel V. Chernyshov, et al.
Publicado: (2026)

Assessing the Impact of Financial Toxicity on Quality of Life in Patients With Hidradenitis Suppurativa: A Cross‐Sectional Survey Study
por: Divya M. Shan, et al.
Publicado: (2026)

Limited Effectiveness of IL ‐17 Inhibitors for Anti‐ TNF ‐Induced Psoriasis in Hidradenitis Suppurativa: A Multicenter Retrospective Study
por: Leonardo Bascón, et al.
Publicado: (2026)

Secukinumab in the Treatment of Moderate‐to‐Severe Hidradenitis Suppurativa: Pooled Pharmacokinetics and Safety Results From the SUNSHINE and SUNRISE Phase 3 Studies
por: Afsaneh Alavi, et al.
Publicado: (2025)

Intralesional Clindamycin and Triamcinolone for Hidradenitis Suppurativa: A Targeted Therapeutic Approach for Rapid Inflammation Control—A Prospective Case Series
por: Caterina Mariarosaria Giorgio, et al.
Publicado: (2025)

Glucagon‐Like Peptide‐1 Receptor Agonists Are Associated With Reduced Disease Severity and Pain in Hidradenitis Suppurativa: A Retrospective Study
por: Zahidul Islam, et al.
Publicado: (2025)

Modestly Increased Incidence of Irritable Bowel Syndrome in Hidradenitis Suppurativa: A Retrospective Cohort Study Using TriNetX
por: Sahithi Talasila, et al.
Publicado: (2026)

The Role of Cutibacterium acnes Biofilm as a Biological Glue in Acne and Dandruff: Current Insights and Future Directions
por: Emma Scott, et al.
Publicado: (2025)

A‐ MACE ‐Ing: A Real‐World Analysis of Semaglutide's Impact on Major Adverse Cardiovascular Events ( MACE ) in Patients With Hidradenitis Suppurativa
por: Rahib K. Islam, et al.
Publicado: (2025)

Neutrophil Extracellular Traps Are Widely Distributed Across Lesional and Perilesional Hidradenitis Suppurativa Skin, and Elevated Serum NET Markers Associate With Moderate to Severe HS Disease
por: Stephanie C. M. van Dalen, et al.
Publicado: (2025)

Serum C‐Reactive Protein as a Potential Indicator for Screening Fecal Calprotectin in Patients With Moderate‐to‐Severe Hidradenitis Suppurativa: A Cross‐Sectional Cohort Study
por: Neslihan Demirel Öğüt, et al.
Publicado: (2025)

Glucagon‐Like Peptide‐1 Receptor Agonists as Adjunctive Therapy for Hidradenitis Suppurativa in Patients With Overweight/Obesity: A Narrative Review of Efficacy, Safety, and Quality‐of‐Life Outcomes
por: Eman Almukhadeb, et al.
Publicado: (2026)

The Successful Use of Upadacitinib as Monotherapy for Hidradenitis Suppurativa and Ulcerative Colitis in the Setting of Refractory Disease
por: Meryem T. Ok, et al.
Publicado: (2024)

Successful Treatment of Pyoderma Gangrenosum Associated With Hidradenitis Suppurativa With Bimekizumab
por: Martha A. Oberg, et al.
Publicado: (2026)

Resolution of Severe Hidradenitis Suppurativa Following Kidney Transplantation
por: Kerem Balan, et al.
Publicado: (2025)